EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Comparison of Immune-Related Adverse Events in Patients Treated with Atezolizumab and Durvalumab: A Critical Concern for Clinical Management

Friday 13 Jun, 12:00 PM - 12:00 PM Glasgow, United Kingdom